Randomised controlled trial of fish oil supplement to treat cancer cachexia

Ann Dewey, Bernard Robert Higgins, C Baughan, Rebecca Jane Stores, Taraneh Dean, Sally Anne Kilburn

Research output: Contribution to journalArticlepeer-review

859 Downloads (Pure)


Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.
Original languageEnglish
Article number002
JournalBAOJ Palliative medicine
Issue number1
Publication statusPublished - 24 Apr 2015


Dive into the research topics of 'Randomised controlled trial of fish oil supplement to treat cancer cachexia'. Together they form a unique fingerprint.

Cite this